CENTER FOR BREAKTHROUGH MEDICINES AT DISCOVERY LABS Trademark

Trademark Overview


On Monday, October 18, 2021, a trademark application was filed for CENTER FOR BREAKTHROUGH MEDICINES AT DISCOVERY LABS with the United States Patent and Trademark Office. The USPTO has given the CENTER FOR BREAKTHROUGH MEDICINES AT DISCOVERY LABS trademark a serial number of 97079346. The federal status of this trademark filing is ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE as of Saturday, October 1, 2022. This trademark is owned by MORNING LIGHT IP, LLC. The CENTER FOR BREAKTHROUGH MEDICINES AT DISCOVERY LABS trademark is filed in the Computer & Software Services & Scientific Services and Medical & Beauty Services & Agricultural Services categories with the following description:

Manufacturing services for others in the fields of gene therapy, modified gene therapy, cell therapy, tissue engineering and biopharmaceuticals; manufacturing services for others in the fields of mammalian cell banks, plasmids, adenovirus, adeno-associated virus (AAV), bacteriophage, lentivirus, retroviruses and other viruses found in humans and animals; manufacturing process consulting

Research and development services in the fields of gene therapy, modified gene therapy, cell therapy, tissue engineering and biopharmaceuticals; consulting services in the fields of research and development for gene therapy, modified gene therapy, cell therapy, tissue engineering and biopharmaceuticals; research and development of new products for others; process development services in the nature of research and development of gene therapy, modified gene therapy, cell therapy, tissue engineering and biopharmaceuticals; scientific research and technical research services, namely, production of cell lines for others using lentivirus technology; scientific research and technical research services relating to producing, assaying and purifying recombinant or manipulated lentivirus; Scientific and technical consulting services relating to producing, assaying, and purifying adenovirus, adeno-associated virus (AAV), bacteriophage, lentivirus, retroviruses and other viruses found in humans and...
center for breakthrough medicines at discovery labs

General Information


Serial Number97079346
Word MarkCENTER FOR BREAKTHROUGH MEDICINES AT DISCOVERY LABS
Filing DateMonday, October 18, 2021
Status602 - ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE
Status DateSaturday, October 1, 2022
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing3000 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Description of MarkThe mark consists of an artistic rendition of a molecular line drawing cut off by two horizonal lines to the right are the words CENTER FOR BREAKTHROUGH MEDICINE AT DISCOVERY LABS.
Goods and ServicesManufacturing services for others in the fields of gene therapy, modified gene therapy, cell therapy, tissue engineering and biopharmaceuticals; manufacturing services for others in the fields of mammalian cell banks, plasmids, adenovirus, adeno-associated virus (AAV), bacteriophage, lentivirus, retroviruses and other viruses found in humans and animals; manufacturing process consulting
Goods and ServicesResearch and development services in the fields of gene therapy, modified gene therapy, cell therapy, tissue engineering and biopharmaceuticals; consulting services in the fields of research and development for gene therapy, modified gene therapy, cell therapy, tissue engineering and biopharmaceuticals; research and development of new products for others; process development services in the nature of research and development of gene therapy, modified gene therapy, cell therapy, tissue engineering and biopharmaceuticals; scientific research and technical research services, namely, production of cell lines for others using lentivirus technology; scientific research and technical research services relating to producing, assaying and purifying recombinant or manipulated lentivirus; Scientific and technical consulting services relating to producing, assaying, and purifying adenovirus, adeno-associated virus (AAV), bacteriophage, lentivirus, retroviruses and other viruses found in humans and animals; advisory services relating to research and development of gene therapy products and biopharmaceuticals; manufacturing support services for others, namely, cGMP (Current Good Manufacturing Practice) quality control testing in support of biopharmaceutical development and manufacturing; quality control for others; quality management services, namely, quality evaluation and analysis, quality assurance, and quality control, in the fields of gene therapy, modified gene therapy, cell therapy, tissue engineering and biopharmaceuticals; material testing; product quality testing; scientific laboratory services; scientific research

Classification Information


International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateThursday, November 4, 2021
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateThursday, November 4, 2021
Primary Code044
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameCENTER FOR BREAKTHROUGH MEDICINES HOLDINGS, LLC
Party Type11 - New Owner Before Publication
Legal Entity Type16 - Limited Liability Company
AddressKING OF PRUSSIA, PA 19406

Party NameMORNING LIGHT IP, LLC
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressRadnor, PA 19087

Trademark Events


Event DateEvent Description
Monday, October 3, 2022ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
Saturday, October 1, 2022ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Friday, March 18, 2022NOTIFICATION OF NON-FINAL ACTION E-MAILED
Friday, March 18, 2022NON-FINAL ACTION E-MAILED
Friday, March 18, 2022NON-FINAL ACTION WRITTEN
Friday, March 4, 2022ASSIGNED TO EXAMINER
Wednesday, January 26, 2022AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Friday, November 5, 2021NOTICE OF DESIGN SEARCH CODE E-MAILED
Thursday, November 4, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Thursday, October 21, 2021NEW APPLICATION ENTERED IN TRAM